Upadacitinib (Standard), CAS [[1310726-60-3]]

Produktübersicht

• Artikelname: Upadacitinib (Standard), CAS [[1310726-60-3]]
• Artikelnummer: MCE-HY-19569R
• Hersteller Artikelnummer: HY-19569R
• Alternativnummer: MCE-HY-19569R-50MG,MCE-HY-19569R-5MG,MCE-HY-19569R-10MG,MCE-HY-19569R-25MG,MCE-HY-19569R-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: ABT-494 (Standard)

Produktbeschreibung

Upadacitinib (Standard) is the analytical standard of Upadacitinib. This product is intended for research and analytical applications. Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research[1][2].

Produkteigenschaften

• Molekulargewicht: 380.37
• Reinheit: 99.73
• CAS Nummer: [1310726-60-3]
• Formel: C17H19F3N6O
• Target-Kategorie: JAK,Reference Standards

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference Standards